Cite
HARVARD Citation
Elewski, B. et al. (2020). Sustained and continuously improved efficacy of tildrakizumab in patients with moderate-to-severe plaque psoriasis. Journal of dermatological treatment. pp. 763-768. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Elewski, B. et al. (2020). Sustained and continuously improved efficacy of tildrakizumab in patients with moderate-to-severe plaque psoriasis. Journal of dermatological treatment. pp. 763-768. [Online].